University of Maryland — Baltimore, Maryland

Public research footprint of University of Maryland, compiled from the ClinicalTrials.gov public registry.

2,597

Registered studies

643

Active

317

Recruiting now

1,461

Completed

393

Stopped or withdrawn

Most-studied conditions

HER2-Negative Breast Carcinoma · Anatomic Stage II Breast Cancer AJCC v8 · Stage II Lung Non-Small Cell Cancer AJCC v7 · Locally Advanced Malignant Solid Neoplasm

Recently updated registry entries

NCT07104032 — IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary… (Recruiting)
NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Maryland?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.